Literature DB >> 20215621

Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads.

A R Thurman1, O Musatovova, S Perdue, R N Shain, J G Baseman, J B Baseman.   

Abstract

The objective of this study was to determine the prevalence and concordance of Mycoplasma genitalium (MG) among Mexican American and African American women and their male sexual partners. Secondary objectives were to determine symptoms of MG infection and persistence of MG after antibiotic therapy. Heterosexual couples were tested for MG and interviewed separately regarding symptoms and behavioural/epidemiologic variables at baseline, six and 12 months. The overall prevalence of MG among women and men was 9.5% and 10.6%, respectively. Subjects were five times more likely to be infected with MG if their sexual partner was MG positive. Among men and women, MG prevalence and mean bacterial loads were similar after receiving single-dose azithromycin, doxycycline or no antibiotics. MG was associated with current urethral discharge in men. No clinical symptoms were specifically diagnostic of MG infection in women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215621     DOI: 10.1258/ijsa.2009.008485

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  22 in total

1.  Chlamydial plasmid-encoded virulence factor Pgp3 interacts with human cathelicidin peptide LL-37 to modulate immune response.

Authors:  Shuping Hou; Xin Sun; Xiaohua Dong; Hui Lin; Lingli Tang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2018-06-26       Impact factor: 2.700

Review 2.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with Mycoplasma genitalium.

Authors:  Mohammad Hossein Ahmadi; Akbar Mirsalehian; Mohammad Ali Sadighi Gilani; Abbas Bahador; Malihe Talebi
Journal:  Infection       Date:  2017-11-09       Impact factor: 3.553

4.  Mycoplasma genitalium Infection in Kenyan and US Women.

Authors:  Jennifer E Balkus; Lisa E Manhart; Jørgen S Jensen; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2018-08       Impact factor: 2.830

Review 5.  Mycoplasma genitalium Infection in Men.

Authors:  Patrick J Horner; David H Martin
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

6.  Epidemiologic factors and urogenital infections associated with preterm birth in a midwestern U.S. population.

Authors:  William A Agger; Danish Siddiqui; Steven D Lovrich; Steven M Callister; Andrew J Borgert; Kenneth W Merkitch; Tina C Mason; Dennis J Baumgardner; James K Burmester; Sanjay K Shukla; Joseph D Welter; Katharina S Stewart; M J Washburn; Howard H Bailey
Journal:  Obstet Gynecol       Date:  2014-11       Impact factor: 7.661

7.  Prevalence of Mycoplasma genitalium and Azithromycin-resistant Infections Among Remnant Clinical Specimens, Los Angeles.

Authors:  Lao-Tzu Allan-Blitz; Elisa Mokany; Shelley Campeau; Rachel Wee; Chelsea Shannon; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2018-09       Impact factor: 2.830

8.  Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama.

Authors:  Li Xiao; Ken B Waites; Barbara Van Der Pol; Kristal J Aaron; Edward W Hook; William M Geisler
Journal:  Sex Transm Dis       Date:  2019-01       Impact factor: 2.830

9.  Transcriptional regulation of MG_149, an osmoinducible lipoprotein gene from Mycoplasma genitalium.

Authors:  Wenbo Zhang; Joel B Baseman
Journal:  Mol Microbiol       Date:  2011-06-22       Impact factor: 3.501

Review 10.  Mycoplasma, Ureaplasma, and adverse pregnancy outcomes: a fresh look.

Authors:  Bryan Larsen; Joseph Hwang
Journal:  Infect Dis Obstet Gynecol       Date:  2010-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.